[Effect of pantethine on the lipoprotein abnormalities in survivors of cerebral infarction (author's transl)].
D002544:Cerebral Infarction / Q000097:blood / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D010204:Pantetheine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D013438:Sulfhydryl Compounds / Q000627:therapeutic use*
D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D013438:Sulfhydryl Compounds; D010204:Pantetheine; C005425:pantethine; D002784:Cholesterol